Bank of America’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-439,902
| Closed | -$14.7M | – | 5817 |
|
|
2026
Q1 | $14.7M | Buy |
439,902
+231,307
| +111% | +$9.07M | ﹤0.01% | 2642 |
|
|
2025
Q4 | $9.66M | Buy |
208,595
+46,497
| +29% | +$2.55M | ﹤0.01% | 2885 |
|
|
2025
Q3 | $11M | Sell |
162,098
-76,545
| -32% | -$5.67M | ﹤0.01% | 3214 |
|
|
2025
Q2 | $20M | Sell |
238,643
-191,416
| -45% | -$14.3M | ﹤0.01% | 2555 |
|
|
2025
Q1 | $30.7M | Buy |
430,059
+380,110
| +761% | +$18.5M | ﹤0.01% | 2022 |
|
|
2024
Q4 | $2.25M | Buy |
49,949
+110
| +0.2% | +$5.7K | ﹤0.01% | 4350 |
|
|
2024
Q3 | $2.52M | Sell |
49,839
-20,816
| -29% | -$997K | ﹤0.01% | 4387 |
|
|
2024
Q2 | $2.88M | Sell |
70,655
-2,171
| -3% | -$92K | ﹤0.01% | 4121 |
|
|
2024
Q1 | $3.12M | Buy |
72,826
+15,356
| +27% | +$695K | ﹤0.01% | 4064 |
|
|
2023
Q4 | $2.31M | Buy |
57,470
+53,572
| +1,374% | +$1.52M | ﹤0.01% | 4260 |
|
|
2023
Q3 | $115K | Buy |
3,898
+1,805
| +86% | +$10.9K | ﹤0.01% | 6192 |
|
|
2023
Q2 | $8.98K | Hold |
2,093
| – | – | ﹤0.01% | 6893 |
|
|
2023
Q1 | $4.48K | Buy |
2,093
+2,092
| +209,200% | +$4.7K | ﹤0.01% | 7091 |
|
|
2022
Q4 | $2 | Buy |
+1
| New | +$1 | ﹤0.01% | 8162 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | – | – | 8705 |
|
|
2021
Q4 | $0 | Buy |
+7
| New | +$73 | ﹤0.01% | 8596 |
|
|
2021
Q3 | – | Sell |
-466
| Closed | -$8K | – | 8361 |
|
|
2021
Q2 | $8K | Sell |
466
-2,322
| -83% | -$39.2K | ﹤0.01% | 7353 |
|
|
2021
Q1 | $53K | Buy |
2,788
+1,932
| +226% | +$62.3K | ﹤0.01% | 6617 |
|
|
2020
Q4 | $24K | Buy |
856
+561
| +190% | +$16.2K | ﹤0.01% | 6549 |
|
|
2020
Q3 | $11K | Sell |
295
-229
| -44% | -$6.69K | ﹤0.01% | 6434 |
|
|
2020
Q2 | $17K | Sell |
524
-21
| -4% | -$910 | ﹤0.01% | 6308 |
|
|
2020
Q1 | $19K | Buy |
545
+543
| +27,150% | +$23.1K | ﹤0.01% | 6196 |
|
|
2019
Q4 | $0 | Sell |
2
-85
| -98% | -$2.17K | ﹤0.01% | 7365 |
|
|
2019
Q3 | $2K | Buy |
+87
| New | +$2.77K | ﹤0.01% | 7011 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7390 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7388 |
|
|
2018
Q4 | – | Sell |
-10
| Closed | -$292 | – | 7352 |
|
|
2018
Q3 | $0 | Buy |
+10
| New | +$363 | ﹤0.01% | 7450 |
|
|
2017
Q3 | – | Sell |
-91
| Closed | -$3K | – | 7244 |
|
|
2017
Q2 | $3K | Buy |
+91
| New | +$4.22K | ﹤0.01% | 6683 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 7202 |
|
|
2016
Q4 | $0 | Sell |
1
-16
| -94% | -$1.11K | ﹤0.01% | 7284 |
|
|
2016
Q3 | $1K | Buy |
+17
| New | +$1.29K | ﹤0.01% | 6963 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7346 |
|
Bank of America's SLNO Position: Q2 2026 in Review
Bank of America sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 439,902 shares — an estimated $14.7M sold.
Bank of America first reported a position in SLNO in Q3 2016 and held it in 27 quarters. The position peaked at $30.7M in Q1 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Bank of America reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Bank of America sold 439,902 Soleno Therapeutics shares in Q2 2026, an estimated $14.7M.
- Bank of America first reported a position in Soleno Therapeutics in Q3 2016 and held it in 27 quarters.
- Bank of America's Soleno Therapeutics position peaked at $30.7M in Q1 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.